PBRCX
Price
$3.71
Change
-$0.02 (-0.54%)
Updated
Jan 30 closing price
Net Assets
97.7M
RYUHX
Price
$19.46
Change
-$0.10 (-0.51%)
Updated
Jan 30 closing price
Net Assets
33.21M
Ad is loading...

PBRCX vs RYUHX

Header iconPBRCX vs RYUHX Comparison
Open Charts PBRCX vs RYUHXBanner chart's image
Federated Hermes Prudent Bear C
Price$3.71
Change-$0.02 (-0.54%)
VolumeN/A
Net Assets97.7M
Rydex Inverse S&P 500® Strategy H
Price$19.46
Change-$0.10 (-0.51%)
VolumeN/A
Net Assets33.21M
PBRCX vs RYUHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PBRCX vs. RYUHX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBRCX is a StrongBuy and RYUHX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
PBRCX has more cash in the bank: 97.7M vs. RYUHX (33.2M). PBRCX pays higher dividends than RYUHX: PBRCX (16.16) vs RYUHX (3.32). PBRCX was incepted earlier than RYUHX: PBRCX (26 years) vs RYUHX (10 years). PBRCX has a lower initial minimum investment than RYUHX: PBRCX (1500) vs RYUHX (2500). RYUHX (-14.41) and PBRCX (-14.42) have marching annual gain over last year. RYUHX (-52.03) and PBRCX (-53.85) have equivalent 5 years return.
PBRCXRYUHXPBRCX / RYUHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years10 years-
Gain YTD-1.842-2.20084%
Front LoadN/AN/A-
Min. Initial Investment1500250060%
Min. Initial Investment IRA250N/A-
Net Assets97.7M33.2M294%
Annual Yield % from dividends16.163.32487%
Returns for 1 year-14.42-14.41100%
Returns for 3 years-23.18-19.17121%
Returns for 5 years-53.85-52.03103%
Returns for 10 years-76.42-73.81104%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LUGDF25.151.34
+5.63%
Lundin Gold Inc.
CIHKY28.130.44
+1.59%
China Merchants Bank Co., Ltd.
BZLFY21.480.31
+1.46%
Bunzl plc
MRAAY8.06-0.04
-0.49%
Murata Manufacturing Inc.
PVCT0.11N/A
-3.17%
Provectus Biopharmaceuticals, Inc.